• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Hero Background
    English
    Chinese
    French
    Japanese
    Korean
    German
    Spanish

    Psoriasis Treatment Market Share

    ID: MRFR/Pharma/2052-HCR
    200 Pages
    Rahul Gotadki
    October 2025

    Psoriasis Treatment Market Size, Growth Research Report By Treatment Type (Topical Treatments, Systemic Treatments, Phototherapy, Biologics), By Administration Route (Oral, Topical, Injectable, Intravenous), By Indication (Plaque Psoriasis, Guttate Psoriasis, Inverse Psoriasis, Pustular Psoriasis), By End User (Hospital, Dermatology Clinics, Homecare Settings) and By Regional (North America, Eu...

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Psoriasis Treatment Market Infographic

    Purchase Options

    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Compare License
    Summary Table of Contents Segmentation Download PDF

    Market Share

    Psoriasis Treatment Market Share Analysis

    Partnerships in the psoriasis treatment market purposely feature on biologic treatments, putting resources into research, improvement, alongside commercialization to ensure a significant piece of the pie, taking special care of the need for cutting edge medicines. Organizations perceive their psoriasis treatment contributions by making spearheading plans, including skin specialists, mix treatments, alongside upgraded conveyance frameworks, to do the trick explicit patient necessities and position themselves as leads. Organizations decisively develop their market section through essential unions, further developing circulation organizations, and joining new business sectors to grow piece of the pie and build up their presence in key regions. Organizations carry out a patient-driven procedure, putting resources into help programs as well as instructive missions to advance patient experience, foster brand devotion, and show a positive standing inside the psoriasis treatment market. Vital evaluating models offset adequacy with moderateness, affirming piece of the pie situating and mounting market entrance by examining market elements, contender rating, and patient socioeconomics. Organizations are intentionally situating themselves by growing particular solutions for paediatric psoriasis, getting an upper hand and securing a huge stake of this particular market. Computerized wellbeing arrangements are being bound together by organizations to revise patient commitment, remote checking, and treatment adherence, lining up with advancing medical services patterns. Putting resources into clinical Research and development is significant for piece of the pie situating in the psoriasis treatment market. This active methodology keeps firms at the vanguard of logical progressions and offers state of the art fixes. Key partnerships and authorizing arrangements are vital for piece of the pie situating, obtaining promising treatments, extending item portfolios, and sharing mastery, adding to showcase intensity and admittance to novel therapies. Biosimilars and generics are vital portion of the overall industry situating procedures for psoriasis treatments. Fruitful administrative exploring permits organizations to offer savvy choices, extending patient access, and catching portion of the overall industry. Adaptable showcasing and marking procedures are significant for keeping an upper hand, guaranteeing associations adjust to advertise patterns, patient inclinations, and contender moves. Keeping severe administrative rules and wellbeing conventions is urgent for acquiring piece of the pie in the psoriasis treatment industry, as it guarantees the constancy and dependability of treatments.

    Market Summary

    As per Market Research Future Analysis, the Global Psoriasis Treatment Market was valued at 19.12 USD Billion in 2024 and is projected to grow to 0.00 USD Billion by 2035, with a CAGR of 0.00% from 2025 to 2035. The market is driven by the increasing prevalence of psoriasis, advancements in treatment options, and rising healthcare expenditure globally.

    Key Market Trends & Highlights

    Key trends driving the Psoriasis Treatment Market include advancements in treatment options and increasing awareness.

    • Psoriasis affects approximately 125 million individuals globally, representing 2% to 3% of the world's population. Biologics are projected to grow from 2.65 USD Billion in 2024 to 3.8 USD Billion by 2035. Topical Treatments are expected to rise from 2.0 USD Billion in 2024 to 3.2 USD Billion by 2035. North America is anticipated to reach 4.5 USD Billion by 2035, leading the market.

    Market Size & Forecast

    2024 Market Size USD 19.12 Billion
    2035 Market Size USD 0.00 Billion
    CAGR (2025-2035) 0.00%
    Largest Regional Market Share in 2024 North America.

    Major Players

    <p>Key players include Pfizer, Merck and Co, AbbVie, Johnson &amp; Johnson, and Novartis.</p>

    Market Trends

    The Psoriasis Treatment market is growing due to key market drivers within it. This growth is due to the increasing awareness concerning psoriasis which, along with its prevalence in numerous regions, prompts the demand for effective treatment options. Moreover, newer therapies are being developed and becoming more accessible due to improvements in biotechnology and pharmacology. There has been a change in treatment approaches, as moderate to severe cases of psoriasis are now treated using Biologics and targeted therapies, which are more effective and gaining greater popularity than before.

    With new developments in telehealth and other digital health solutions, there is a greater focus on caring for the patients, which has uncovered new opportunities for the market.

    This development enables more efficient patient management and treatment adherence, improving results for patients with psoriasis. Furthermore, recent partnerships between pharmaceutical companies and health care providers focus on developing new research and treatment solutions, leveraging networked care to fulfill existing medical gaps. Regarding new developments, there has been a marked increase in attention and funding directed toward psoriasis research, particularly in exploring the disease and its comorbidities. The increase in skin health dietary supplements and natural treatment approaches is expanding as more patients look for alternative ways to cope with their disease.

    The international scope of the market implies that policy makers and regulatory bodies in different areas of the world are also influencing the treatment landscape, promising more active innovative therapy development while ensuring patient safety. All in all, these trends demonstrate a responsive and proactive market geared toward addressing the needs of patients and health care practitioners across the globe.

     

    <p>The increasing prevalence of psoriasis, coupled with advancements in biologic therapies, suggests a transformative shift in treatment paradigms that may enhance patient outcomes and quality of life.</p>

    National Institutes of Health

    Psoriasis Treatment Market Market Drivers

    Market Growth Projections

    The Global Psoriasis Treatment Market Industry is poised for substantial growth, with projections indicating a market value of 7.45 USD Billion in 2024 and an anticipated increase to 12 USD Billion by 2035. This growth trajectory reflects a compound annual growth rate of 4.43% from 2025 to 2035. Factors such as rising prevalence, advancements in treatment options, and increased healthcare expenditure contribute to this positive outlook. The market's expansion is likely to be driven by continuous innovation and the introduction of new therapies, catering to the diverse needs of patients suffering from psoriasis.

    Rising Prevalence of Psoriasis

    The increasing prevalence of psoriasis globally is a primary driver of the Global Psoriasis Treatment Market Industry. It is estimated that around 125 million people worldwide are affected by this chronic skin condition. This growing patient population necessitates the development and availability of effective treatment options. As awareness of psoriasis rises, more individuals seek medical attention, contributing to market growth. The Global Psoriasis Treatment Market is projected to reach 7.45 USD Billion in 2024, reflecting the urgent need for innovative therapies and management strategies to address this widespread health issue.

    Growing Awareness and Education

    The rise in awareness and education regarding psoriasis plays a pivotal role in shaping the Global Psoriasis Treatment Market Industry. Initiatives by healthcare organizations and advocacy groups aim to educate the public about the condition, its symptoms, and available treatments. This heightened awareness encourages individuals to seek medical advice and treatment, leading to earlier diagnosis and intervention. As more people become informed about psoriasis, the demand for effective therapies is likely to increase. This trend aligns with the projected market growth, as the industry adapts to meet the needs of a more educated patient population.

    Increased Healthcare Expenditure

    Rising healthcare expenditure across various regions is a crucial factor propelling the Global Psoriasis Treatment Market Industry. As governments and private sectors allocate more funds towards healthcare, patients gain better access to dermatological services and psoriasis treatments. This trend is particularly evident in developed nations, where healthcare budgets are expanding to accommodate chronic disease management. The increasing investment in healthcare infrastructure supports the availability of advanced treatment options, thereby enhancing patient outcomes. Consequently, the market is expected to experience a compound annual growth rate of 4.43% from 2025 to 2035, reflecting the positive impact of increased healthcare spending.

    Advancements in Treatment Options

    Innovations in treatment modalities significantly influence the Global Psoriasis Treatment Market Industry. Recent developments include biologics, systemic therapies, and topical treatments that have shown promising results in managing psoriasis symptoms. For instance, biologics targeting specific immune pathways have transformed treatment approaches, offering patients more effective and personalized options. As these therapies gain regulatory approval and become more accessible, they are likely to drive market expansion. The anticipated growth trajectory suggests that the market could reach 12 USD Billion by 2035, indicating a robust demand for advanced treatment solutions.

    Regulatory Support for New Treatments

    Regulatory bodies' support for the approval of new psoriasis treatments significantly impacts the Global Psoriasis Treatment Market Industry. Streamlined approval processes and incentives for developing innovative therapies encourage pharmaceutical companies to invest in research and development. This regulatory environment fosters the introduction of novel treatment options, enhancing competition within the market. As new therapies receive approval, they provide patients with more choices, potentially improving treatment outcomes. The ongoing regulatory support is expected to sustain market growth, contributing to the overall expansion of the industry.

    Market Segment Insights

    Psoriasis Treatment Market Treatment Type Insights

    <p>The Global Psoriasis Treatment Market exhibits significant growth within the Treatment Type segment, where the valuations for various treatment methods highlight the diverse approaches to managing this chronic skin condition. In 2024, the Global Psoriasis Treatment Market revenue reach approximately 7.45 USD Billion, with substantial contributions from its various treatment categories. As an effective measure for mild to moderate psoriasis, Topical Treatments are valued at 2.0 USD Billion in 2024 and projected to rise to 3.2 USD Billion by 2035, indicating consistency in their demand due to their accessibility and ease of use.</p>

    <p>Systemic Treatments, which are often reserved for more severe cases, represent a notable segment as well, beginning at a valuation of 1.8 USD Billion in 2024 and expected to grow to 3.0 USD Billion by 2035. The effectiveness of these treatments in providing relief from more intense symptoms contributes to their importance in the market.</p>

    <p>Phototherapy, another essential treatment option, is valued at 1.0 USD Billion in 2024 with expectations to double this value to 2.0 USD Billion by 2035, reflecting its role as a viable treatment for patients who prefer non-pharmaceutical options or require combination therapies.Biologics lead this market segment with a projection starting value of 2.65 USD Billion in 2024, increasing to 3.8 USD Billion by 2035; this category's biologic drugs showcase remarkable efficacy in targeting specific pathways in immune response, thereby offering significant benefits for moderate to severe psoriasis patients.&nbsp;</p>

    Psoriasis Treatment Market Administration Route Insights

    <p>The Administration Route segment of the Global Psoriasis Treatment Market plays a crucial role in determining how therapies are delivered to patients suffering from this chronic skin condition. As the Global Psoriasis Treatment Market revenue is expected to reach 7.45 billion USD , the market is largely driven by the efficiency and convenience of various administration routes. Among the different methods, topical treatments are widely adopted due to their ease of use and direct application to affected areas, making them particularly significant in managing mild to moderate psoriasis.</p>

    <p>Oral therapies are also gaining traction, primarily for their systemic effect and patient preference for non-invasive treatment options. Injectable therapies, often considered for more severe cases, offer rapid action and potent effects, while intravenous administration is utilized for patients requiring immediate therapeutic interventions. The choice of administration routes is influenced by factors such as patient compliance, the severity of the disease, and the healthcare setting, contributing to the overall market growth and dynamics.&nbsp;</p>

    <p>As the Global Psoriasis Treatment Market statistics show, these varied routes facilitate better management and enhance patient outcomes, indicating a healthy evolution in treatment approaches.</p>

    Psoriasis Treatment Market Indication Insights

    <p>The Global Psoriasis Treatment Market valued at 7.45 USD Billion in 2024, with a significant emphasis on the various indicatives of psoriasis. This market comprises diverse types of psoriasis, including Plaque, Guttate, Inverse, and Pustular Psoriasis, each representing distinct manifestations of the condition. Plaque Psoriasis, being the most prevalent form, dominates the market due to its widespread occurrence and the chronic nature that requires ongoing treatment intervention.&nbsp;</p>

    <p>Guttate Psoriasis is another notable form often triggered by infections, making it significant in market consideration as it presents unique treatment challenges.Inverse Psoriasis, characterized by red, shiny lesions in skin folds, showcases a crucial segment due to its specific management needs. Pustular Psoriasis, though less common, highlights the necessity for targeted therapies, further shaping the market landscape.&nbsp;</p>

    <p>The growth of the Global Psoriasis Treatment Market is propelled by advancements in treatment modalities and an increasing focus on patient-centered care, providing abundant opportunities for stakeholders to innovate while addressing pressing challenges. With diverse segments addressing varied patient profiles, the market is poised for evolution, driven by ongoing Research and Development efforts.</p>

    Psoriasis Treatment Market End User Insights

    <p>The Global Psoriasis Treatment Market is poised for notable growth, expected to reach a valuation of 7.45 USD Billion . This market's segmentation includes critical areas such as hospitals, dermatology clinics, and homecare settings, with each playing a vital role in patient care. Hospitals serve a high volume of patients requiring advanced treatment options, making them a dominant force within the market. Dermatology clinics provide specialized care, leading to tailored treatments for individuals, thereby enhancing the effectiveness of therapies selected for specific patient needs.</p>

    <p>Homecare settings are increasingly significant due to their convenience and the rising patient preference for treatments that can be administered in their own environments, significantly impacting patient adherence. The Global Psoriasis Treatment Market data reflects ongoing trends towards personalized medicine and the expanding role of telemedicine, providing opportunities to enhance care access. Furthermore, the aging global population, increasing incidence of psoriasis, and ongoing Research and Development efforts are fundamental growth drivers throughout this market.</p>

    <p>However, challenges such as treatment costs and patient access remain pertinent as market stakeholders navigate the evolving healthcare landscape. Understanding these segments and their interdependencies is essential for leveraging existing opportunities and addressing challenges in the Global Psoriasis Treatment Market industry.</p>

    Get more detailed insights about Psoriasis Treatment Market Research Report - Forecast till 2035

    Regional Insights

    The Global Psoriasis Treatment Market showcases significant regional diversity with North America dominating the landscape. In 2024, North America holds a valuation of 2.85 USD Billion, growing to 4.5 USD Billion by 2035, marking it as a substantial contributor to the market growth. Europe follows closely, with a valuation of 2.25 USD Billion in 2024 and projected to reach 3.5 USD Billion by 2035, indicating a strong market presence.

    The Asia-Pacific (APAC) region is also noteworthy, valued at 1.75 USD Billion in 2024, with expectations to rise to 2.5 USD Billion in 2035, reflecting growing demand for psoriasis treatment options in emerging markets.

    South America, though smaller, is on an upward trajectory with a value of 0.45 USD Billion in 2024, anticipated to grow to 0.7 USD Billion by 2035. The Middle East and Africa (MEA) region currently holds a value of 0.15 USD Billion in 2024, expected to double by 2035, showing gradual market development. Factors supporting this regional segmentation include increasing healthcare access, rising prevalence of psoriasis, and a growing awareness of treatment options among consumers. 

    Each region's unique healthcare infrastructure and market needs present distinct opportunities for growth in the Global Psoriasis Treatment Market.The varied market statistics across regions underscore the importance of targeting specific regional strategies to optimize outreach and product availability.

    Psoriasis Treatment Market Region

    Key Players and Competitive Insights

    The Global Psoriasis Treatment Market has become increasingly competitive, driven by the rising prevalence of psoriasis and growing awareness among healthcare providers and patients about the effectiveness of various treatment options. The market has seen a surge in the development of innovative therapies, including biologics, systemic treatments, and topical applications, aimed at providing effective relief for patients suffering from this chronic skin condition. 

    Competition among key players in this market is characterized by the continuous introduction of novel products, strategic partnerships, and aggressive marketing strategies to capture larger market shares. The dynamic nature of the industry is further influenced by advancements in research and technology, which have enabled faster identification and targeting of new therapeutic pathways, ultimately benefiting patients looking for improved treatment modalities.

    Pfizer has established a strong presence in the Global Psoriasis Treatment Market through its innovative treatment options that address the diverse needs of psoriasis patients. The company has successfully leveraged its research capabilities to develop effective biologics that have gained significant traction in the market. Pfizer's strengths lie in its extensive portfolio, robust clinical data supporting its products, and a dedicated focus on improving patient outcomes. The company's commitment to ongoing research and development ensures the continuous evolution of its treatment offerings, allowing it to respond effectively to the changing market dynamics and patient requirements.

    Pfizer's strategic collaborations and partnerships further bolster its market position, allowing for streamlined distribution and enhanced market access across various regions.

    Merck and Co has made significant inroads into the Global Psoriasis Treatment Market, recognized for its innovative therapies designed to tackle the challenges associated with this skin disease. The company boasts an impressive lineup of key products that include both biologics and oral medications specifically tailored for psoriasis treatment. Merck and Co's strengths stem from its strong research foundation and ongoing focus on clinical trials that demonstrate the efficacy and safety of its products.

    The company's ability to adapt to changing market conditions is evident in its strategic mergers and acquisitions that bolster its product portfolio and enhance its market footprint. 

    These efforts, combined with its relentless commitment to patient-centric approaches, have positioned Merck and Co as a formidable player in the Global Psoriasis Treatment Market, ensuring a competitive edge through continuous innovation and widespread geographical reach.

    Key Companies in the Psoriasis Treatment Market market include

    Industry Developments

    In recent months, the Global Psoriasis Treatment Market has experienced significant developments, particularly with companies like AbbVie making strides in Research and Development for improved biologic therapies. In September 2023, Pfizer launched a new clinical trial aimed at exploring innovative treatments for moderate to severe psoriasis, showcasing ongoing commitment in this sector. Similarly, in August 2023, Merck announced advancements in their psoriasis portfolio, aimed at enhancing patient outcomes. 

    Major companies including Johnson and Johnson and Novartis continue to engage in improving treatment options, while GSK has been actively investing in research to tap into emerging treatment modalities. In terms of mergers and acquisitions, in July 2023, AstraZeneca completed the acquisition of a portfolio from a small biotech company focused on skin diseases, significantly enhancing their capabilities in the psoriasis market. 

    Reports indicate that there is growing momentum for biologic therapies, which has led to increased valuations for key players in the market. Over the past two to three years, the industry has witnessed a marked increase in interest and investment, particularly in targeting more effective treatment options for patients, as the demand for innovative solutions continues to rise globally.

    Future Outlook

    Psoriasis Treatment Market Future Outlook

    <p>The Global Psoriasis Treatment Market is projected to grow at a 4.43% CAGR from 2024 to 2035, driven by advancements in biologics, increasing prevalence, and rising awareness.</p>

    New opportunities lie in:

    • <p>Develop targeted therapies for specific psoriasis subtypes to enhance treatment efficacy. Leverage telemedicine platforms for remote patient monitoring and personalized treatment plans. Invest in patient education programs to improve adherence and treatment outcomes.</p>

    <p>By 2035, the market is expected to exhibit robust growth, reflecting advancements in treatment options and increased patient access.</p>

    Market Segmentation

    Psoriasis Treatment Market End User Outlook

    • {""=>["Hospital"
    • "Dermatology Clinics"
    • "Homecare Settings"]}

    Psoriasis Treatment Market Regional Outlook

    • {""=>["North America"
    • "Europe"
    • "South America"
    • "Asia Pacific"
    • "Middle East and Africa"]}

    Psoriasis Treatment Market Indication Outlook

    • {""=>["Plaque Psoriasis"
    • "Guttate Psoriasis"
    • "Inverse Psoriasis"
    • "Pustular Psoriasis"]}

    Psoriasis Treatment Market Treatment Type Outlook

    • {""=>["Topical Treatments"
    • "Systemic Treatments"
    • "Phototherapy"
    • "Biologics"]}

    Psoriasis Treatment Market Administration Route Outlook

    • {""=>["Oral"
    • "Topical"
    • "Injectable"
    • "Intravenous"]}

    Report Scope

    Report Attribute/Metric Source: Details
    MARKET SIZE 2023 7.14(USD Billion)
    MARKET SIZE 2024 7.45(USD Billion)
    MARKET SIZE 2035 12.0(USD Billion)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 0.00% (2025 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    MARKET FORECAST PERIOD 2025 - 2035
    HISTORICAL DATA 2019 - 2023
    MARKET FORECAST UNITS USD Billion
    KEY COMPANIES PROFILED Pfizer, Merck and Co, AbbVie, Johnson and Johnson, Lilly, GSK, UCB, Celgene, Novartis, Regeneron Pharmaceuticals, BristolMyers Squibb, AstraZeneca, Amgen, Eli Lilly and Company, Sanofi
    SEGMENTS COVERED Treatment Type, Administration Route, Indication, End User, Regional
    KEY MARKET OPPORTUNITIES Increasing prevalence of psoriasis, Growing demand for biologics, Expansion of telemedicine solutions, Advancements in personalized medicine, Rising awareness and education initiatives
    KEY MARKET DYNAMICS rising prevalence of psoriasis, increasing demand for biologics, advancements in treatment technologies, growing awareness and education, favorable reimbursement policies
    COUNTRIES COVERED North America, Europe, APAC, South America, MEA
    Market Size 2024 19.12
    Market Size 2025 20.62
    Base Year 2024
    Market Forecast Period 2025 - 2035

    Market Highlights

    Author

    Rahul Gotadki
    Assistant Manager

    She holds an experience of about 6+ years in market research and business consulting, working under the spectrum of information communication technology, telecommunications and semiconductor domains. aarti conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. her expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

    Leave a Comment

    Latest Comments

    John Doe
    john@example.com

    This is a great article! Really helped me understand the topic better.

    Posted on July 23, 2025, 10:15 AM
    Jane Smith
    jane@domain.com

    Thanks for sharing this. I’ve bookmarked it for later reference.

    Posted on July 22, 2025, 7:45 PM
    View All

    FAQs

    Which region holds the largest market share in the Global Psoriasis Treatment Market in 2024?

    In 2024, North America is expected to hold the largest market share valued at 2.85 USD Billion.

    What will the market value of Europe be in the Global Psoriasis Treatment Market by 2035?

    The market value in Europe is projected to be 3.5 USD Billion by 2035.

    What is the estimated market size for Biologics in the Global Psoriasis Treatment Market in 2024?

    Biologics are expected to be valued at 2.65 USD Billion in 2024.

    What opportunities exist in the Global Psoriasis Treatment Market for systemic treatments by 2035?

    Systemic treatments are projected to grow to 3.0 USD Billion by 2035, indicating significant market opportunities.

    Who are the key competitors in the Global Psoriasis Treatment Market?

    Major players in the market include Pfizer, Merck and Co, AbbVie, and Johnson and Johnson among others.

    What is the expected market value for Phototherapy in the Global Psoriasis Treatment Market in 2024?

    Phototherapy is anticipated to be valued at 1.0 USD Billion in 2024.

    What challenges does the Global Psoriasis Treatment Market face in growth?

    The market faces challenges from regulatory hurdles and the high cost of development for new treatments.

    1. --- "
    2. Table of Contents
    3. EXECUTIVE SUMMARY
    4. Market Overview
    5. Key Findings
    6. Market Segmentation
    7. Competitive Landscape
    8. Challenges and Opportunities
    9. Future Outlook
    10. MARKET INTRODUCTION
    11. Definition
    12. Scope of the study
    13. Research Objective
    14. Assumption
    15. Limitations
    16. RESEARCH METHODOLOGY
    17. Overview
    18. Data Mining
    19. Secondary Research
    20. Primary Research
    21. Primary Interviews and Information Gathering Process
    22. Breakdown of Primary Respondents
    23. Forecasting Model
    24. Market Size Estimation
    25. Bottom-Up Approach
    26. Top-Down Approach
    27. Data Triangulation
    28. Validation
    29. MARKET DYNAMICS
    30. Overview
    31. Drivers
    32. Restraints
    33. Opportunities
    34. MARKET FACTOR ANALYSIS
    35. Value chain Analysis
    36. Porter's Five Forces Analysis
    37. Bargaining Power of Suppliers
    38. Bargaining Power of Buyers
    39. Threat of New Entrants
    40. Threat of Substitutes
    41. Intensity of Rivalry
    42. COVID-19 Impact Analysis
    43. Market Impact Analysis
    44. Regional Impact
    45. Opportunity and Threat Analysis
    46. Psoriasis Treatment Market, BY Treatment Type (USD Billion)
    47. Topical Treatments
    48. Systemic Treatments
    49. Phototherapy
    50. Biologics
    51. Psoriasis Treatment Market, BY Administration Route (USD Billion)
    52. Oral
    53. Topical
    54. Injectable
    55. Intravenous
    56. Psoriasis Treatment Market, BY Indication (USD Billion)
    57. Plaque Psoriasis
    58. Guttate Psoriasis
    59. Inverse Psoriasis
    60. Pustular Psoriasis
    61. Psoriasis Treatment Market, BY End User (USD Billion)
    62. Hospital
    63. Dermatology Clinics
    64. Homecare Settings
    65. Psoriasis Treatment Market, BY Regional (USD Billion)
    66. North America
    67. US
    68. Canada
    69. Europe
    70. Germany
    71. UK
    72. France
    73. Russia
    74. Italy
    75. Spain
    76. Rest of Europe
    77. APAC
    78. China
    79. India
    80. Japan
    81. South Korea
    82. Malaysia
    83. Thailand
    84. Indonesia
    85. Rest of APAC
    86. South America
    87. Brazil
    88. Mexico
    89. Argentina
    90. Rest of South America
    91. MEA
    92. GCC Countries
    93. South Africa
    94. Rest of MEA
    95. Competitive Landscape
    96. Overview
    97. Competitive Analysis
    98. Market share Analysis
    99. Major Growth Strategy in the Psoriasis Treatment Market
    100. Competitive Benchmarking
    101. Leading Players in Terms of Number of Developments in the Psoriasis Treatment Market
    102. Key developments and growth strategies
    103. New Product Launch/Service Deployment
    104. Merger & Acquisitions
    105. Joint Ventures
    106. Major Players Financial Matrix
    107. Sales and Operating Income
    108. Major Players R&D Expenditure. 2023
    109. Company Profiles
    110. Pfizer
    111. Financial Overview
    112. Products Offered
    113. Key Developments
    114. SWOT Analysis
    115. Key Strategies
    116. Merck and Co
    117. Financial Overview
    118. Products Offered
    119. Key Developments
    120. SWOT Analysis
    121. Key Strategies
    122. AbbVie
    123. Financial Overview
    124. Products Offered
    125. Key Developments
    126. SWOT Analysis
    127. Key Strategies
    128. Johnson and Johnson
    129. Financial Overview
    130. Products Offered
    131. Key Developments
    132. SWOT Analysis
    133. Key Strategies
    134. Lilly
    135. Financial Overview
    136. Products Offered
    137. Key Developments
    138. SWOT Analysis
    139. Key Strategies
    140. GSK
    141. Financial Overview
    142. Products Offered
    143. Key Developments
    144. SWOT Analysis
    145. Key Strategies
    146. UCB
    147. Financial Overview
    148. Products Offered
    149. Key Developments
    150. SWOT Analysis
    151. Key Strategies
    152. Celgene
    153. Financial Overview
    154. Products Offered
    155. Key Developments
    156. SWOT Analysis
    157. Key Strategies
    158. Novartis
    159. Financial Overview
    160. Products Offered
    161. Key Developments
    162. SWOT Analysis
    163. Key Strategies
    164. Regeneron Pharmaceuticals
    165. Financial Overview
    166. Products Offered
    167. Key Developments
    168. SWOT Analysis
    169. Key Strategies
    170. BristolMyers Squibb
    171. Financial Overview
    172. Products Offered
    173. Key Developments
    174. SWOT Analysis
    175. Key Strategies
    176. AstraZeneca
    177. Financial Overview
    178. Products Offered
    179. Key Developments
    180. SWOT Analysis
    181. Key Strategies
    182. Amgen
    183. Financial Overview
    184. Products Offered
    185. Key Developments
    186. SWOT Analysis
    187. Key Strategies
    188. Eli Lilly and Company
    189. Financial Overview
    190. Products Offered
    191. Key Developments
    192. SWOT Analysis
    193. Key Strategies
    194. Sanofi
    195. Financial Overview
    196. Products Offered
    197. Key Developments
    198. SWOT Analysis
    199. Key Strategies
    200. Appendix
    201. References
    202. Related Reports

    Psoriasis Treatment Market Segmentation

    Psoriasis Treatment Market By Treatment Type (USD Billion, 2019-2035)

    Topical Treatments

    Systemic Treatments

    Phototherapy

    Biologics

    Psoriasis Treatment Market By Administration Route (USD Billion, 2019-2035)

    Oral

    Topical

    Injectable

    Intravenous

    Psoriasis Treatment Market By Indication (USD Billion, 2019-2035)

    Plaque Psoriasis

    Guttate Psoriasis

    Inverse Psoriasis

    Pustular Psoriasis

    Psoriasis Treatment Market By End User (USD Billion, 2019-2035)

    Hospital

    Dermatology Clinics

    Homecare Settings

    Psoriasis Treatment Market By Regional (USD Billion, 2019-2035)

    North America

    Europe

    South America

    Asia Pacific

    Middle East and Africa

    Psoriasis Treatment Market Regional Outlook (USD Billion, 2019-2035)

    North America Outlook (USD Billion, 2019-2035)

    North America Psoriasis Treatment Market by Treatment Type

    Topical Treatments

    Systemic Treatments

    Phototherapy

    Biologics

    North America Psoriasis Treatment Market by Administration Route Type

    Oral

    Topical

    Injectable

    Intravenous

    North America Psoriasis Treatment Market by Indication Type

    Plaque Psoriasis

    Guttate Psoriasis

    Inverse Psoriasis

    Pustular Psoriasis

    North America Psoriasis Treatment Market by End User Type

    Hospital

    Dermatology Clinics

    Homecare Settings

    North America Psoriasis Treatment Market by Regional Type

    US

    Canada

    US Outlook (USD Billion, 2019-2035)

    US Psoriasis Treatment Market by Treatment Type

    Topical Treatments

    Systemic Treatments

    Phototherapy

    Biologics

    US Psoriasis Treatment Market by Administration Route Type

    Oral

    Topical

    Injectable

    Intravenous

    US Psoriasis Treatment Market by Indication Type

    Plaque Psoriasis

    Guttate Psoriasis

    Inverse Psoriasis

    Pustular Psoriasis

    US Psoriasis Treatment Market by End User Type

    Hospital

    Dermatology Clinics

    Homecare Settings

    CANADA Outlook (USD Billion, 2019-2035)

    CANADA Psoriasis Treatment Market by Treatment Type

    Topical Treatments

    Systemic Treatments

    Phototherapy

    Biologics

    CANADA Psoriasis Treatment Market by Administration Route Type

    Oral

    Topical

    Injectable

    Intravenous

    CANADA Psoriasis Treatment Market by Indication Type

    Plaque Psoriasis

    Guttate Psoriasis

    Inverse Psoriasis

    Pustular Psoriasis

    CANADA Psoriasis Treatment Market by End User Type

    Hospital

    Dermatology Clinics

    Homecare Settings

    Europe Outlook (USD Billion, 2019-2035)

    Europe Psoriasis Treatment Market by Treatment Type

    Topical Treatments

    Systemic Treatments

    Phototherapy

    Biologics

    Europe Psoriasis Treatment Market by Administration Route Type

    Oral

    Topical

    Injectable

    Intravenous

    Europe Psoriasis Treatment Market by Indication Type

    Plaque Psoriasis

    Guttate Psoriasis

    Inverse Psoriasis

    Pustular Psoriasis

    Europe Psoriasis Treatment Market by End User Type

    Hospital

    Dermatology Clinics

    Homecare Settings

    Europe Psoriasis Treatment Market by Regional Type

    Germany

    UK

    France

    Russia

    Italy

    Spain

    Rest of Europe

    GERMANY Outlook (USD Billion, 2019-2035)

    GERMANY Psoriasis Treatment Market by Treatment Type

    Topical Treatments

    Systemic Treatments

    Phototherapy

    Biologics

    GERMANY Psoriasis Treatment Market by Administration Route Type

    Oral

    Topical

    Injectable

    Intravenous

    GERMANY Psoriasis Treatment Market by Indication Type

    Plaque Psoriasis

    Guttate Psoriasis

    Inverse Psoriasis

    Pustular Psoriasis

    GERMANY Psoriasis Treatment Market by End User Type

    Hospital

    Dermatology Clinics

    Homecare Settings

    UK Outlook (USD Billion, 2019-2035)

    UK Psoriasis Treatment Market by Treatment Type

    Topical Treatments

    Systemic Treatments

    Phototherapy

    Biologics

    UK Psoriasis Treatment Market by Administration Route Type

    Oral

    Topical

    Injectable

    Intravenous

    UK Psoriasis Treatment Market by Indication Type

    Plaque Psoriasis

    Guttate Psoriasis

    Inverse Psoriasis

    Pustular Psoriasis

    UK Psoriasis Treatment Market by End User Type

    Hospital

    Dermatology Clinics

    Homecare Settings

    FRANCE Outlook (USD Billion, 2019-2035)

    FRANCE Psoriasis Treatment Market by Treatment Type

    Topical Treatments

    Systemic Treatments

    Phototherapy

    Biologics

    FRANCE Psoriasis Treatment Market by Administration Route Type

    Oral

    Topical

    Injectable

    Intravenous

    FRANCE Psoriasis Treatment Market by Indication Type

    Plaque Psoriasis

    Guttate Psoriasis

    Inverse Psoriasis

    Pustular Psoriasis

    FRANCE Psoriasis Treatment Market by End User Type

    Hospital

    Dermatology Clinics

    Homecare Settings

    RUSSIA Outlook (USD Billion, 2019-2035)

    RUSSIA Psoriasis Treatment Market by Treatment Type

    Topical Treatments

    Systemic Treatments

    Phototherapy

    Biologics

    RUSSIA Psoriasis Treatment Market by Administration Route Type

    Oral

    Topical

    Injectable

    Intravenous

    RUSSIA Psoriasis Treatment Market by Indication Type

    Plaque Psoriasis

    Guttate Psoriasis

    Inverse Psoriasis

    Pustular Psoriasis

    RUSSIA Psoriasis Treatment Market by End User Type

    Hospital

    Dermatology Clinics

    Homecare Settings

    ITALY Outlook (USD Billion, 2019-2035)

    ITALY Psoriasis Treatment Market by Treatment Type

    Topical Treatments

    Systemic Treatments

    Phototherapy

    Biologics

    ITALY Psoriasis Treatment Market by Administration Route Type

    Oral

    Topical

    Injectable

    Intravenous

    ITALY Psoriasis Treatment Market by Indication Type

    Plaque Psoriasis

    Guttate Psoriasis

    Inverse Psoriasis

    Pustular Psoriasis

    ITALY Psoriasis Treatment Market by End User Type

    Hospital

    Dermatology Clinics

    Homecare Settings

    SPAIN Outlook (USD Billion, 2019-2035)

    SPAIN Psoriasis Treatment Market by Treatment Type

    Topical Treatments

    Systemic Treatments

    Phototherapy

    Biologics

    SPAIN Psoriasis Treatment Market by Administration Route Type

    Oral

    Topical

    Injectable

    Intravenous

    SPAIN Psoriasis Treatment Market by Indication Type

    Plaque Psoriasis

    Guttate Psoriasis

    Inverse Psoriasis

    Pustular Psoriasis

    SPAIN Psoriasis Treatment Market by End User Type

    Hospital

    Dermatology Clinics

    Homecare Settings

    REST OF EUROPE Outlook (USD Billion, 2019-2035)

    REST OF EUROPE Psoriasis Treatment Market by Treatment Type

    Topical Treatments

    Systemic Treatments

    Phototherapy

    Biologics

    REST OF EUROPE Psoriasis Treatment Market by Administration Route Type

    Oral

    Topical

    Injectable

    Intravenous

    REST OF EUROPE Psoriasis Treatment Market by Indication Type

    Plaque Psoriasis

    Guttate Psoriasis

    Inverse Psoriasis

    Pustular Psoriasis

    REST OF EUROPE Psoriasis Treatment Market by End User Type

    Hospital

    Dermatology Clinics

    Homecare Settings

    APAC Outlook (USD Billion, 2019-2035)

    APAC Psoriasis Treatment Market by Treatment Type

    Topical Treatments

    Systemic Treatments

    Phototherapy

    Biologics

    APAC Psoriasis Treatment Market by Administration Route Type

    Oral

    Topical

    Injectable

    Intravenous

    APAC Psoriasis Treatment Market by Indication Type

    Plaque Psoriasis

    Guttate Psoriasis

    Inverse Psoriasis

    Pustular Psoriasis

    APAC Psoriasis Treatment Market by End User Type

    Hospital

    Dermatology Clinics

    Homecare Settings

    APAC Psoriasis Treatment Market by Regional Type

    China

    India

    Japan

    South Korea

    Malaysia

    Thailand

    Indonesia

    Rest of APAC

    CHINA Outlook (USD Billion, 2019-2035)

    CHINA Psoriasis Treatment Market by Treatment Type

    Topical Treatments

    Systemic Treatments

    Phototherapy

    Biologics

    CHINA Psoriasis Treatment Market by Administration Route Type

    Oral

    Topical

    Injectable

    Intravenous

    CHINA Psoriasis Treatment Market by Indication Type

    Plaque Psoriasis

    Guttate Psoriasis

    Inverse Psoriasis

    Pustular Psoriasis

    CHINA Psoriasis Treatment Market by End User Type

    Hospital

    Dermatology Clinics

    Homecare Settings

    INDIA Outlook (USD Billion, 2019-2035)

    INDIA Psoriasis Treatment Market by Treatment Type

    Topical Treatments

    Systemic Treatments

    Phototherapy

    Biologics

    INDIA Psoriasis Treatment Market by Administration Route Type

    Oral

    Topical

    Injectable

    Intravenous

    INDIA Psoriasis Treatment Market by Indication Type

    Plaque Psoriasis

    Guttate Psoriasis

    Inverse Psoriasis

    Pustular Psoriasis

    INDIA Psoriasis Treatment Market by End User Type

    Hospital

    Dermatology Clinics

    Homecare Settings

    JAPAN Outlook (USD Billion, 2019-2035)

    JAPAN Psoriasis Treatment Market by Treatment Type

    Topical Treatments

    Systemic Treatments

    Phototherapy

    Biologics

    JAPAN Psoriasis Treatment Market by Administration Route Type

    Oral

    Topical

    Injectable

    Intravenous

    JAPAN Psoriasis Treatment Market by Indication Type

    Plaque Psoriasis

    Guttate Psoriasis

    Inverse Psoriasis

    Pustular Psoriasis

    JAPAN Psoriasis Treatment Market by End User Type

    Hospital

    Dermatology Clinics

    Homecare Settings

    SOUTH KOREA Outlook (USD Billion, 2019-2035)

    SOUTH KOREA Psoriasis Treatment Market by Treatment Type

    Topical Treatments

    Systemic Treatments

    Phototherapy

    Biologics

    SOUTH KOREA Psoriasis Treatment Market by Administration Route Type

    Oral

    Topical

    Injectable

    Intravenous

    SOUTH KOREA Psoriasis Treatment Market by Indication Type

    Plaque Psoriasis

    Guttate Psoriasis

    Inverse Psoriasis

    Pustular Psoriasis

    SOUTH KOREA Psoriasis Treatment Market by End User Type

    Hospital

    Dermatology Clinics

    Homecare Settings

    MALAYSIA Outlook (USD Billion, 2019-2035)

    MALAYSIA Psoriasis Treatment Market by Treatment Type

    Topical Treatments

    Systemic Treatments

    Phototherapy

    Biologics

    MALAYSIA Psoriasis Treatment Market by Administration Route Type

    Oral

    Topical

    Injectable

    Intravenous

    MALAYSIA Psoriasis Treatment Market by Indication Type

    Plaque Psoriasis

    Guttate Psoriasis

    Inverse Psoriasis

    Pustular Psoriasis

    MALAYSIA Psoriasis Treatment Market by End User Type

    Hospital

    Dermatology Clinics

    Homecare Settings

    THAILAND Outlook (USD Billion, 2019-2035)

    THAILAND Psoriasis Treatment Market by Treatment Type

    Topical Treatments

    Systemic Treatments

    Phototherapy

    Biologics

    THAILAND Psoriasis Treatment Market by Administration Route Type

    Oral

    Topical

    Injectable

    Intravenous

    THAILAND Psoriasis Treatment Market by Indication Type

    Plaque Psoriasis

    Guttate Psoriasis

    Inverse Psoriasis

    Pustular Psoriasis

    THAILAND Psoriasis Treatment Market by End User Type

    Hospital

    Dermatology Clinics

    Homecare Settings

    INDONESIA Outlook (USD Billion, 2019-2035)

    INDONESIA Psoriasis Treatment Market by Treatment Type

    Topical Treatments

    Systemic Treatments

    Phototherapy

    Biologics

    INDONESIA Psoriasis Treatment Market by Administration Route Type

    Oral

    Topical

    Injectable

    Intravenous

    INDONESIA Psoriasis Treatment Market by Indication Type

    Plaque Psoriasis

    Guttate Psoriasis

    Inverse Psoriasis

    Pustular Psoriasis

    INDONESIA Psoriasis Treatment Market by End User Type

    Hospital

    Dermatology Clinics

    Homecare Settings

    REST OF APAC Outlook (USD Billion, 2019-2035)

    REST OF APAC Psoriasis Treatment Market by Treatment Type

    Topical Treatments

    Systemic Treatments

    Phototherapy

    Biologics

    REST OF APAC Psoriasis Treatment Market by Administration Route Type

    Oral

    Topical

    Injectable

    Intravenous

    REST OF APAC Psoriasis Treatment Market by Indication Type

    Plaque Psoriasis

    Guttate Psoriasis

    Inverse Psoriasis

    Pustular Psoriasis

    REST OF APAC Psoriasis Treatment Market by End User Type

    Hospital

    Dermatology Clinics

    Homecare Settings

    South America Outlook (USD Billion, 2019-2035)

    South America Psoriasis Treatment Market by Treatment Type

    Topical Treatments

    Systemic Treatments

    Phototherapy

    Biologics

    South America Psoriasis Treatment Market by Administration Route Type

    Oral

    Topical

    Injectable

    Intravenous

    South America Psoriasis Treatment Market by Indication Type

    Plaque Psoriasis

    Guttate Psoriasis

    Inverse Psoriasis

    Pustular Psoriasis

    South America Psoriasis Treatment Market by End User Type

    Hospital

    Dermatology Clinics

    Homecare Settings

    South America Psoriasis Treatment Market by Regional Type

    Brazil

    Mexico

    Argentina

    Rest of South America

    BRAZIL Outlook (USD Billion, 2019-2035)

    BRAZIL Psoriasis Treatment Market by Treatment Type

    Topical Treatments

    Systemic Treatments

    Phototherapy

    Biologics

    BRAZIL Psoriasis Treatment Market by Administration Route Type

    Oral

    Topical

    Injectable

    Intravenous

    BRAZIL Psoriasis Treatment Market by Indication Type

    Plaque Psoriasis

    Guttate Psoriasis

    Inverse Psoriasis

    Pustular Psoriasis

    BRAZIL Psoriasis Treatment Market by End User Type

    Hospital

    Dermatology Clinics

    Homecare Settings

    MEXICO Outlook (USD Billion, 2019-2035)

    MEXICO Psoriasis Treatment Market by Treatment Type

    Topical Treatments

    Systemic Treatments

    Phototherapy

    Biologics

    MEXICO Psoriasis Treatment Market by Administration Route Type

    Oral

    Topical

    Injectable

    Intravenous

    MEXICO Psoriasis Treatment Market by Indication Type

    Plaque Psoriasis

    Guttate Psoriasis

    Inverse Psoriasis

    Pustular Psoriasis

    MEXICO Psoriasis Treatment Market by End User Type

    Hospital

    Dermatology Clinics

    Homecare Settings

    ARGENTINA Outlook (USD Billion, 2019-2035)

    ARGENTINA Psoriasis Treatment Market by Treatment Type

    Topical Treatments

    Systemic Treatments

    Phototherapy

    Biologics

    ARGENTINA Psoriasis Treatment Market by Administration Route Type

    Oral

    Topical

    Injectable

    Intravenous

    ARGENTINA Psoriasis Treatment Market by Indication Type

    Plaque Psoriasis

    Guttate Psoriasis

    Inverse Psoriasis

    Pustular Psoriasis

    ARGENTINA Psoriasis Treatment Market by End User Type

    Hospital

    Dermatology Clinics

    Homecare Settings

    REST OF SOUTH AMERICA Outlook (USD Billion, 2019-2035)

    REST OF SOUTH AMERICA Psoriasis Treatment Market by Treatment Type

    Topical Treatments

    Systemic Treatments

    Phototherapy

    Biologics

    REST OF SOUTH AMERICA Psoriasis Treatment Market by Administration Route Type

    Oral

    Topical

    Injectable

    Intravenous

    REST OF SOUTH AMERICA Psoriasis Treatment Market by Indication Type

    Plaque Psoriasis

    Guttate Psoriasis

    Inverse Psoriasis

    Pustular Psoriasis

    REST OF SOUTH AMERICA Psoriasis Treatment Market by End User Type

    Hospital

    Dermatology Clinics

    Homecare Settings

    MEA Outlook (USD Billion, 2019-2035)

    MEA Psoriasis Treatment Market by Treatment Type

    Topical Treatments

    Systemic Treatments

    Phototherapy

    Biologics

    MEA Psoriasis Treatment Market by Administration Route Type

    Oral

    Topical

    Injectable

    Intravenous

    MEA Psoriasis Treatment Market by Indication Type

    Plaque Psoriasis

    Guttate Psoriasis

    Inverse Psoriasis

    Pustular Psoriasis

    MEA Psoriasis Treatment Market by End User Type

    Hospital

    Dermatology Clinics

    Homecare Settings

    MEA Psoriasis Treatment Market by Regional Type

    GCC Countries

    South Africa

    Rest of MEA

    GCC COUNTRIES Outlook (USD Billion, 2019-2035)

    GCC COUNTRIES Psoriasis Treatment Market by Treatment Type

    Topical Treatments

    Systemic Treatments

    Phototherapy

    Biologics

    GCC COUNTRIES Psoriasis Treatment Market by Administration Route Type

    Oral

    Topical

    Injectable

    Intravenous

    GCC COUNTRIES Psoriasis Treatment Market by Indication Type

    Plaque Psoriasis

    Guttate Psoriasis

    Inverse Psoriasis

    Pustular Psoriasis

    GCC COUNTRIES Psoriasis Treatment Market by End User Type

    Hospital

    Dermatology Clinics

    Homecare Settings

    SOUTH AFRICA Outlook (USD Billion, 2019-2035)

    SOUTH AFRICA Psoriasis Treatment Market by Treatment Type

    Topical Treatments

    Systemic Treatments

    Phototherapy

    Biologics

    SOUTH AFRICA Psoriasis Treatment Market by Administration Route Type

    Oral

    Topical

    Injectable

    Intravenous

    SOUTH AFRICA Psoriasis Treatment Market by Indication Type

    Plaque Psoriasis

    Guttate Psoriasis

    Inverse Psoriasis

    Pustular Psoriasis

    SOUTH AFRICA Psoriasis Treatment Market by End User Type

    Hospital

    Dermatology Clinics

    Homecare Settings

    REST OF MEA Outlook (USD Billion, 2019-2035)

    REST OF MEA Psoriasis Treatment Market by Treatment Type

    Topical Treatments

    Systemic Treatments

    Phototherapy

    Biologics

    REST OF MEA Psoriasis Treatment Market by Administration Route Type

    Oral

    Topical

    Injectable

    Intravenous

    REST OF MEA Psoriasis Treatment Market by Indication Type

    Plaque Psoriasis

    Guttate Psoriasis

    Inverse Psoriasis

    Pustular Psoriasis

    REST OF MEA Psoriasis Treatment Market by End User Type

    Hospital

    Dermatology Clinics

    Homecare Settings

    Infographic

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Get Free Sample

    Related Reports

    Regional Reports
    Country Reports

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne

    Founder
    Case Study
    Chemicals and Materials
    Global Magnesium Sulfate Market – Forecast till 2027